Neuro

Research from anesthesiology, pain and critical care journals, sourced from PubMed.

Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.

AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.

Last successful paper check: 16 Nov 2026 17:18 UTC. 0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
Article J Clin Anesth Published 14 Nov 2026
Perioperative management of patients with recent concussion undergoing noncardiac extracranial surgery: A modified Delphi consensus study.
AI-generated abstract summary · verify against the original paper
  • A two-round modified Delphi consensus study of 35 experts, 33 of them anesthesiologists from 17 countries, addressed adults with recent concussion having noncardiac extracranial surgery.
  • The panel rated statements on a five-point Likert scale, with consensus defined a priori as at least 75% agreement and strong consensus as at least 85%.
  • Of 16 Round 2 statements, 13 reached consensus, including unanimous agreement on preoperative screening and avoiding hypoxemia, hypotension, and marked hypertension, and strong consensus (97%) for generally deferring elective surgery until symptoms resolve.
  • Consensus was not reached for regional or monitored anesthesia care over general anesthesia (74%), EEG-guided depth monitoring (73%), or cautious long-acting neuraxial opioid use (69%); the authors describe the output as an expert-informed framework, not an evidence-based guideline.
PubMed indexed 14 Nov 2026 Imported 15 Nov 2026 Elganga M et al. Publisher NeuroPerioperative medicine
Meta-analysis Pain Med Published 13 Nov 2026
Perioperative Pregabalin for Persistent Postsurgical Pain After Lumbar Spine Surgery In Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of five placebo-controlled RCTs (335 participants) testing perioperative pregabalin in adults undergoing elective lumbar spine surgery.
  • Pregabalin was compared with placebo, with the primary outcome being pain intensity at 3 months, pooled across four trials (275 participants).
  • Pregabalin did not reduce 3-month pain intensity (SMD 0.03, 95% CI -0.41 to 0.47; I² 69%; low certainty).
  • Functional disability was lower with pregabalin (SMD -0.51, 95% CI -0.86 to -0.16), but the differences fell below minimal important change thresholds, with very low certainty.
PubMed indexed 13 Nov 2026 Imported 13 Nov 2026 Correia DG et al. Publisher Chronic painNeuroPerioperative medicine
Article Anesthesiology Published 13 Nov 2026
Childhood Exposure to General Anesthesia for Surgery: Identification of a Subtle Postoperative Cognitive Phenotype.
AI-generated abstract summary · verify against the original paper
  • Ambidirectional cohort of 77 children aged 9-11, with or without prior surgical general anesthesia exposure, tested on a cognitive battery.
  • Eight measures covered inhibitory control, cognitive flexibility, working memory, and visuo-spatial attention, analyzed with mixed-effects and exploratory latent profile models.
  • No overall exposure effect on executive function (χ²(1)=.01, p=.92), but exposure was linked to lower odds of the Efficient profile (OR 0.71, 95% CI [0.705, 0.710], p<.001).
  • Exposed children showed higher global-local precedence (estimate 0.53, 95% CI [0.04, 1.01], p=.036), which the authors describe as a possible post-operative phenotype.
PubMed indexed 22 Oct 2026 Imported 9 Nov 2026 Salaün JP et al. Publisher NeuroPediatric
Meta-analysis Crit Care Med Published 12 Nov 2026
New-Onset Atrial Fibrillation in Critically Ill Patients: A Systematic Review of In-Hospital and Post-Discharge Outcomes.
AI-generated abstract summary · verify against the original paper
  • A Bayesian systematic review and meta-analysis of 54 studies, including 367,896 critically ill adults, examined new-onset atrial fibrillation in general ICUs and high-dependency units.
  • It compared post-discharge systemic thromboembolism in patients with and without new-onset atrial fibrillation, with follow-up ranging from 1.5 months to 5 years.
  • Pooled NOAF incidence was 10.6% (95% CrI 8.6-12.9%), and post-discharge thromboembolism risk was 7.1% (95% CrI 4.5-11.0%). Relative risk was 1.94 (95% CrI 1.23-3.29) across six studies, rising to 2.01 with adjustment.
  • Anticoagulation use was low, at 32.9% in-hospital and 35.9% post-discharge, and 23.9% of patients with NOAF were later diagnosed with atrial fibrillation.
PubMed indexed 12 Nov 2026 Imported 13 Nov 2026 Tan SWZ et al. Publisher Critical careNeuro
RCT Crit Care Med Published 11 Nov 2026
The Effect of Guanfacine on Delirium in Surgical and Trauma ICU Patients: A Pilot Randomized Clinical Trial.
AI-generated abstract summary · verify against the original paper
  • Single-center, randomized, double-blind, placebo-controlled pilot trial of 100 critically ill adults with CAM-ICU-confirmed delirium in surgical and trauma ICUs.
  • Patients received 2 mg guanfacine or matching placebo nightly for up to 14 days, or until ICU discharge or delirium resolution.
  • Median delirium and coma-free days were 2 (IQR 0-6) with guanfacine versus 1 (IQR 0-4) with placebo (p = 0.02) in unadjusted analyses, but not significant after adjustment.
  • Feasibility targets were mostly met, with 100% adherence, retention, and data completeness, though COVID-19 limited recruitment to 0.9 patients/week; authors judge the signal worth a multicenter trial.
PubMed indexed 11 Nov 2026 Imported 12 Nov 2026 Barker AB et al. Publisher Critical careNeuro
Article Crit Care Med Published 11 Nov 2026
Composite Endpoints in Critical Care Delirium Trials.
AI-generated abstract summary · verify against the original paper
  • This methods paper uses data from the MENDS trial to examine composite endpoints for critical care delirium trials.
  • It evaluates two existing composites: delirium- and coma-free days, and a ranked endpoint that treats death as worst and orders delirium- and coma-free days among survivors.
  • The authors describe how to define treatment effects on each composite, assess their clinical interpretability, and visualize how effects accumulate over follow-up.
  • They provide practical recommendations for composite endpoints that could extend to other randomized trials using similar endpoints.
PubMed indexed 11 Nov 2026 Imported 12 Nov 2026 Smith BB et al. Publisher Critical careNeuro
Article Crit Care Med Published 11 Nov 2026
Circulating Cell-Free Mitochondrial DNA, Delirium, and Long-Term Cognitive Impairment in Critically Ill Adults With Sepsis: A Prospective Cohort Study.
AI-generated abstract summary · verify against the original paper
  • Multicenter prospective cohort of 480 adults with sepsis plus shock and/or acute respiratory failure, enrolled in medical and surgical ICUs in Nashville, TN.
  • Plasma ccf-mtDNA was measured on study days 1, 3, and 5 and related to delirium and coma; no intervention was given.
  • Higher ccf-mtDNA was associated with lower odds of delirium (OR 0.93, 95% CI 0.86-0.99; p = 0.048), but not with coma or 3- or 12-month cognition.
  • Mortality association was marginal (HR 1.09, 95% CI 0.99-1.20; p = 0.08); the authors urge cautious interpretation until the finding is replicated.
PubMed indexed 11 Nov 2026 Imported 12 Nov 2026 Onyemekwu CA et al. Publisher Critical careNeuro
Review Br J Anaesth Published 9 Nov 2026
Chronic preoperative benzodiazepine use and perioperative outcomes: a scoping review.
AI-generated abstract summary · verify against the original paper
  • This scoping review of 130 studies, mostly observational cohorts (83.8%), mapped literature on chronic preoperative benzodiazepine use and perioperative outcomes.
  • Chronic use was defined inconsistently, ranging from 1 month to over 1 year before surgery, and duration was not systematically defined in 47.7% of studies.
  • Postoperative opioid use (40.8% of studies) and delirium or cognitive impairment (14.6%) were the most examined outcomes, with most reporting adverse associations.
  • The authors conclude chronic use is a clinically relevant but inconsistently defined exposure, and that causal inference is not possible without risk-of-bias assessment and prospective studies.
PubMed indexed 9 Nov 2026 Imported 10 Nov 2026 Nurse R et al. Publisher NeuroPerioperative medicine
Article Eur J Anaesthesiol Published 6 Nov 2026
Postoperative delirium and 1-year functional decline, institutionalization and mortality.
AI-generated abstract summary · verify against the original paper
  • In a prospective multicentre observational study of 2442 adult surgical patients at 43 Spanish hospitals, 1899 completed 1-year telephone follow-up.
  • The exposure was postoperative delirium within 48 hours, screened with CAM, CAM-ICU or the telephone-administered 4AT depending on setting.
  • Delirium was independently associated with a 4.60-point higher WHODAS 2.0 score at 1 year (95% CI 1.57 to 7.64, P = 0.003), and with institutionalisation (OR 2.5, 95% CI 1.07 to 5.84, P = 0.03).
  • Mortality was 16.7% versus 3.1% (P < 0.001), and the authors conclude that delirium is a key perioperative complication that supports prevention and structured long-term follow-up.
PubMed indexed 20 Oct 2026 Imported 9 Nov 2026 de la Varga-Martínez O et al. Publisher Neuro
Review Eur Heart J Published 6 Nov 2026
Delirium in cardiovascular medicine.
AI-generated abstract summary · verify against the original paper
  • This state-of-the-art review covers delirium epidemiology, mechanisms, diagnosis, prevention and treatment across cardiovascular medicine, drawing on interdisciplinary expert input.
  • It identifies risk factors such as advanced age, baseline cognitive impairment, cerebrovascular disease, longer operative times, complications and systemic inflammation.
  • Non-pharmacological multicomponent prevention is described as strongly supported, while preventive pharmacologic use remains controversial; dexmedetomidine is noted for ICU settings.
  • The authors conclude that systematic risk assessment and multimodal prevention should be standard care, with more high-quality studies needed for cardiovascular-specific guidelines.
PubMed indexed 19 Feb 2026 Imported 9 Nov 2026 Cekaj E et al. Publisher CardiacNeuroPerioperative medicine
Review World Neurosurg Published 3 Nov 2026
Beyond Weight Loss: A Scoping Review and Thematic Analysis of GLP-1 Receptor Agonists Across the Neurosurgical Landscape.
AI-generated abstract summary · verify against the original paper
  • Scoping review (PRISMA-ScR) of 48 included studies from 1,342 screened, mostly US-based and retrospective (43/48).
  • Included studies examined GLP-1 receptor agonist exposure in adults with spinal, intracranial, or cerebrovascular disease, grouped into three themes.
  • Spinal fusion studies repeatedly linked perioperative exposure to lower pseudarthrosis, though some reported more postoperative complications; IIH studies linked it to lower papilledema and shunt placement.
  • The authors judge benefit signals most consistent in spinal fusion and IIH, but adverse effects and database overlap limit causal inference, and they call for prospective trials.
PubMed indexed 3 Nov 2026 Imported 9 Nov 2026 Diamandi J et al. Publisher Neuro
Review Eur Geriatr Med Published 30 Oct 2026
Effects of perioperative dexmedetomidine on postoperative delirium in older surgical patients: an updated meta-analysis of randomized controlled trials.
AI-generated abstract summary · verify against the original paper
  • Meta-analysis of 22 RCTs including 4161 older surgical patients under general anesthesia, searched across PubMed, Embase and CENTRAL through July 2026.
  • Compared perioperative intravenous dexmedetomidine with control for prevention of postoperative delirium, the primary outcome.
  • Dexmedetomidine reduced postoperative delirium (RR 0.56, 95% CI 0.47 to 0.66; P<0.00001; I² 24%) and PONV (RR 0.79, 95% CI 0.62 to 0.99; P=0.04).
  • Dexmedetomidine was associated with more intraoperative and postoperative bradycardia and more intraoperative hypotension.
PubMed indexed 31 Oct 2026 Imported 9 Nov 2026 Shi CG et al. Publisher NeuroPerioperative medicinePharmacology
Review J Clin Anesth Published 30 Oct 2026
Processed electroencephalogram-guided anesthesia and its impact on postoperative delirium and perioperative efficiency: A systematic review and meta-analysis.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of 87 RCTs enrolling 30,611 adults undergoing surgical, endoscopic, or dental procedures.
  • Compared pEEG-guided with non-pEEG-guided anesthesia on anesthetic drug use, postoperative delirium, and perioperative efficiency measures.
  • pEEG reduced propofol use (SMD -0.42) and volatile agent use (SMD -1.27), and postoperative delirium risk fell (RR 0.73, 95% CI 0.63 to 0.84).
  • Extubation, wake-up, orientation, and PACU stay were all shorter with pEEG, with BIS showing the most consistent benefit and substantial heterogeneity for several outcomes.
PubMed indexed 30 Oct 2026 Imported 9 Nov 2026 Hormis A et al. Publisher NeuroPerioperative medicine
RCT Br J Anaesth Published 29 Oct 2026
Effect of remimazolam versus propofol anaesthesia on postoperative delirium in neurovascular surgery: a randomised noninferiority trial.
AI-generated abstract summary · verify against the original paper
  • Single-centre, double-blind randomised noninferiority trial of 686 adults having elective neurovascular surgery, analysed as a modified intention-to-treat population.
  • Patients received remimazolam-based TIVA with flumazenil reversal at emergence or propofol-based TIVA, both with remifentanil.
  • Postoperative delirium within 5 days occurred in 12.8% (44/344) with remimazolam and 10.8% (37/342) with propofol; risk difference 1.97 percentage points (95% CI -2.85 to 6.80).
  • Remimazolam met the prespecified noninferiority criterion, and that group had less intraoperative hypotension below a MAP of 65 mm Hg and more operating-room extubation.
PubMed indexed 29 Oct 2026 Imported 9 Nov 2026 Kim J et al. Publisher NeuroPharmacology
Review Rev Esp Anestesiol Reanim (Engl Ed) Published 29 Oct 2026
Dexmedetomidine versus propofol for the prevention of postoperative delirium in older adults undergoing regional anaesthesia: A systematic review and meta-analysis.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of five randomized trials, totaling 1613 adults aged 60 or older having surgery under regional anesthesia.
  • Compared intraoperative dexmedetomidine with propofol, with delirium assessed using CAM or CAM-ICU.
  • Delirium occurred in 7.7% of dexmedetomidine patients versus 16.7% with propofol (RR 0.48, 95% CI 0.36-0.64; P < .001), with low heterogeneity (I² = 13.4%).
  • The authors conclude dexmedetomidine is associated with less postoperative delirium, and they rated the certainty of evidence as moderate by GRADE.
PubMed indexed 29 Oct 2026 Imported 9 Nov 2026 Estefó M et al. Publisher NeuroPharmacologyRegional
Meta-analysis Int J Spine Surg Published 29 Oct 2026
Do Preoperative Glucagon-Like Peptide-1 Receptor Agonists Influence Lumbar Fusion Outcomes? A Systematic Review and Meta-Analysis.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of seven retrospective cohorts (28,525 patients) comparing lumbar fusion patients with and without preoperative GLP-1RA exposure.
  • Six of the seven studies used propensity score matching or another matching strategy to balance the comparison groups.
  • No significant association with reoperation or revision (OR 0.74, 95% CI 0.44-1.24; P = 0.25) or postoperative infection (OR 0.83, 95% CI 0.68-1.00; P = 0.05).
  • The authors found no signal of increased postoperative risk and called for prospective studies with standardized exposure definitions and perioperative management protocols.
PubMed indexed 17 Sep 2026 Imported 9 Nov 2026 Alves MLM et al. Publisher NeuroPerioperative medicine
Review Diagnostics (Basel) Published 27 Oct 2026
Postoperative Delirium Across the Perioperative Pathway: A Structured Narrative Review of Clinical Maturity and Implementation Priorities.
AI-generated abstract summary · verify against the original paper
  • This structured narrative review synthesizes adult postoperative delirium evidence across the perioperative pathway, searching major databases plus ESAIC and ASA resources and reference lists.
  • It classifies prevention and therapeutic strategies by clinical maturity, target population, and implementation readiness rather than by pooled effect size.
  • The authors report that no single anesthetic technique, processed-EEG target, blood-pressure threshold, cerebral oximetry strategy, or agent consistently prevents delirium across surgical populations.
  • Multicomponent non-pharmacological prevention has the most consistent support, dexmedetomidine appears context-dependent, and biomarkers and metabolic targets remain investigational.
PubMed indexed 14 Nov 2026 Imported 14 Nov 2026 Katona OB et al. Publisher NeuroPerioperative medicine
Review J Clin Anesth Published 25 Oct 2026
Preoperative cognitive training for preventing perioperative neurocognitive disorders: A systematic review and meta-analysis with trial sequential analysis and meta-regression of randomised controlled trials.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of 13 RCTs including 1446 patients comparing preoperative cognitive training with usual care.
  • Primary outcomes were postoperative delirium, delayed neurocognitive recovery, and postoperative neurocognitive disorder.
  • Training was associated with lower postoperative delirium risk (RR 0.53, 95% CI 0.36-0.77, P=0.001), though certainty was rated low.
  • The delayed neurocognitive recovery reduction (RR 0.66, 95% CI 0.46-0.96) was not robust to sensitivity analyses, and traditional training may outperform digital training for delirium.
PubMed indexed 25 Oct 2026 Imported 9 Nov 2026 Gao Y et al. Publisher NeuroPerioperative medicine
Article Anesth Analg Published 22 Oct 2026
Association of Altered Anteriorization of Electroencephalographic Alpha Oscillation During Transition to Unconsciousness With Postoperative Delirium: A Prospective Observational Study.
AI-generated abstract summary · verify against the original paper
  • Prospective exploratory observational study of 83 elderly patients from one tertiary hospital under sevoflurane anesthesia with 19-channel EEG, after 17 excluded for artifacts.
  • Exposure was EEG alpha anteriorization and network efficiency across induction, maintenance, emergence, and PACU phases, compared between patients with and without postoperative delirium.
  • Just before loss of responsiveness, nondelirium patients showed frontal alpha power of 4.24 vs -0.88 dB (P = .007), whereas delirium patients showed minimal change.
  • During maintenance, the delirium group had longer averaged characteristic path lengths (4.49 ± 0.62 vs 3.57 ± 0.16, P = .026, FDR-corrected), suggesting reduced network efficiency.
PubMed indexed 23 Oct 2026 Imported 9 Nov 2026 Kim YS et al. Publisher Neuro
Review Front Pediatr Published 21 Oct 2026
Dose- and endpoint-dependent effects of perioperative esketamine in children: evidence from a targeted review.
AI-generated abstract summary · verify against the original paper
  • This mini review synthesizes a targeted search of pediatric esketamine studies covering analgesia, sedation, propofol injection pain, and emergence delirium or agitation.
  • Randomized trials and meta-analyses generally report fewer emergence delirium or agitation events after low intravenous esketamine doses, mostly during sevoflurane adenotonsillectomy.
  • Direct dose-comparison evidence in that setting shows increasing benefit up to 0.5 mg/kg intravenously, with no upper efficacy or safety boundary identified.
  • The authors conclude that 0.2-0.5 mg/kg IV was the best-studied range for emergence prevention, not a validated therapeutic window, and call for direct dose-timing trials.
PubMed indexed 5 Nov 2026 Yang Y et al. Publisher NeuroPediatricPerioperative medicinePharmacology
Article Spine J Published 21 Oct 2026
Outcomes after Posterior Cervical Spine Surgery: A Matched Cohort Analysis and Comparison of GLP-1 Receptor Agonist Use and Bariatric Surgery in Patients with Type 2 Diabetes.
AI-generated abstract summary · verify against the original paper
  • Retrospective PearlDiver Mariner database study of patients with type 2 diabetes on metformin who underwent posterior cervical surgery from 2010 to 2023, using propensity-score matching.
  • Preoperative GLP-1 receptor agonist users were compared with matched non-users and with patients who had prior bariatric surgery.
  • GLP-1 users had lower odds of perioperative pneumonitis (OR 0.57; 95% CI 0.43-0.75; p<0.001) and of 90-day revision surgery (OR 0.33; 95% CI 0.29-0.36; p<0.001).
  • Lower odds persisted for 2-year revision surgery and nutritional deficiency, and no significant differences were found versus the bariatric surgery cohort.
PubMed indexed 22 Oct 2026 Imported 9 Nov 2026 Rivera N et al. Publisher NeuroPerioperative medicine
Article Br J Anaesth Published 19 Oct 2026
Brain-derived tau in plasma and cerebrospinal fluid after surgery: a prospective cohort substudy.
AI-generated abstract summary · verify against the original paper
  • Prospective cohort substudy of adults undergoing hip or knee arthroplasty, measuring plasma and CSF brain-derived tau before neuraxial anaesthesia and up to 48 h after surgery.
  • Plasma brain-derived tau peaked at 4 h with a 254% rise (IQR 137-382%, P<0.001) and was still 31% above baseline at 48 h (6-75%, P<0.001).
  • CSF brain-derived tau was unchanged at 4 h but rose 51% by 48 h (21-82%, P=0.004), and plasma and CSF levels were inversely associated (β=-0.71, P<0.001).
  • The authors suggest the early plasma rise reflects redistribution of tau from the CNS rather than concomitant neuronal injury; higher plasma levels were also associated with worse cognition at 3 months.
PubMed indexed 19 Oct 2026 Imported 9 Nov 2026 Thorsson M et al. Publisher Neuro